A detailed history of Financial Perspectives, Inc transactions in Argenx Se stock. As of the latest transaction made, Financial Perspectives, Inc holds 104 shares of ARGX stock, worth $61,509. This represents 0.02% of its overall portfolio holdings.

Number of Shares
104
Previous 104 -0.0%
Holding current value
$61,509
Previous $44.7 Million 26.05%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jan 09, 2024

SELL
$257.11 - $319.92 $7.34 Million - $9.13 Million
-28,537 Reduced 99.64%
104 $31.3 Million
Q1 2021

Jan 09, 2024

BUY
$268.3 - $380.31 $7.66 Million - $10.9 Million
28,537 Added 27439.42%
28,641 $104,000
Q3 2020

Jan 09, 2024

BUY
$215.51 - $272.51 $22,413 - $28,341
104 New
104 $27.3 Million

Others Institutions Holding ARGX

About ARGENX SE


  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $32.7B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track Financial Perspectives, Inc Portfolio

Follow Financial Perspectives, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Perspectives, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Perspectives, Inc with notifications on news.